We previously observed that SMS1 deficiency–mediated glucosylceramide accumulation caused nonalcoholic fatty liver diseases (NAFLD), including nonalcoholic steatohepatitis (NASH) and liver fibrosis. The gene discussed is SGMS1; the disease is metabolic dysfunction-associated steatotic liver disease.